1.Allergen immunotherapy.
Korean Journal of Medicine 2002;62(3):244-249
No absract available.
Desensitization, Immunologic*
2.Practice Patterns of Allergen Immunotherapy in Korea: Where Are We?.
Allergy, Asthma & Immunology Research 2013;5(5):249-250
No abstract available.
Desensitization, Immunologic
6.Successful desensitization of pemetrexed-induced anaphylaxis in a patient with malignant mesothelioma.
Jeonghwan YOUK ; Hyunkyung PARK ; Kwang Nam JIN ; Hyun Jong MOON ; Min Suk YANG ; Ki Hwan KIM ; Jin Soo KIM
The Korean Journal of Internal Medicine 2017;32(3):563-565
No abstract available.
Anaphylaxis*
;
Desensitization, Immunologic
;
Humans
;
Mesothelioma*
;
Pemetrexed
7.Successful desensitization of pemetrexed-induced anaphylaxis in a patient with malignant mesothelioma.
Jeonghwan YOUK ; Hyunkyung PARK ; Kwang Nam JIN ; Hyun Jong MOON ; Min Suk YANG ; Ki Hwan KIM ; Jin Soo KIM
The Korean Journal of Internal Medicine 2017;32(3):563-565
No abstract available.
Anaphylaxis*
;
Desensitization, Immunologic
;
Humans
;
Mesothelioma*
;
Pemetrexed
9.Allergen Immunotherapy: Past, Present, and Future.
Marek JUTEL ; Anna KOSOWSKA ; Sylwia SMOLINSKA
Allergy, Asthma & Immunology Research 2016;8(3):191-197
Allergen-specific immunotherapy (AIT), although in clinical use for more than a century, is still the only causal treatment of allergic diseases. The safety and efficacy of AIT has been demonstrated in a large number of clinical trials. In addition to allergy symptom reduction AIT plays an essential role in preventing new allergies and asthma and shows long-term effects after discontinuation of treatment. Ideally, it is capable of curing allergy. However, AIT is not effective in all allergic individuals and is not equally effective in the treatment of various hypersensitivities to different allergens. For many years, the route of administration and the vaccine compositions have been evolving. Still there is a strong need for research in the field of new AIT modalities to increase its effectiveness and safety. Growing evidence on immunological effects of AIT, especially new T cell subsets involved in antigen/allergen tolerance, provides novel concepts for safer and more effective vaccination. Pharmacoeconomic studies have demonstrated a clear advantage of AIT over pharmacologic therapies.
Allergens
;
Asthma
;
Desensitization, Immunologic*
;
Hypersensitivity
;
Immunotherapy
;
T-Lymphocyte Subsets
;
Vaccination
10.Updates on desensitization for hypersensitivity reactions related to chemotherapy.
Suh Young LEE ; Min Suk YANG ; Jae Woo JUNG ; Mi Jung OH ; Chang Han PARK ; Seong Wook SOHN ; Hye Ryun KANG ; Young Joo CHO
Allergy, Asthma & Respiratory Disease 2013;1(4):295-302
As the use of chemotherapeutic agents increased rapidly in recent years, more patients are under the potential risk of chemotherapy related adverse reactions. Multiple regular exposures to the same drug by chemotherapy protocol may increase the risk of sensitization to a chemotherapeutic agent, which can result in hypersensitivity reactions. Once severe hypersensitivity reactions occur, causative drugs should be avoided. However, a substitute with equal efficacy is not always available. When there is no effective alternative, desensitization is a safe tool for maintenance of chemotherapeutic agents causing hypersensitivity reaction. In this review, we introduce the latest knowledge about desensitization protocol for chemotherapeutic agents which are frequently used recently.
Antineoplastic Agents
;
Desensitization, Immunologic
;
Drug Hypersensitivity
;
Drug Therapy*
;
Humans
;
Hypersensitivity*
Result Analysis
Print
Save
E-mail